Cochrane · systematic review · CD006712

Local anaesthesia for pain control in first trimester surgical abortion

Renner, R-M, Ennis, M, McKercher, AE, et al. · Cochrane Database of Systematic Reviews · 2024 · Cochrane Library

Fertility RegulationAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
57
current version
GRADE rated
29
No studies
28
Included studies
NR
No studies 28 · 49.1%Ungraded 0 · 0%Very low 3 · 5.3%Low 10 · 17.5%Moderate 12 · 21.1%High 4 · 7%

Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.

Questions and results

Summary of findings table ‐ 20 mL 1% lidocaine paracervical block compared to sham paracervical block for people requesting a surgical abortion at less than 11 weeks? gestation

Population: people requesting a surgical abortion at less than 11 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs sham paracervical block
no estimate extracted1 study · 120 participantsHigh
Pain with aspirationa,b
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs sham paracervical block
no estimate extracted1 study · 120 participantsHigh
Pain during procedure ‐ not measured
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs sham paracervical block
no estimate extractedNRNo studies

Summary of findings table ‐ 20 mL 1% lidocaine paracervical block compared to normal saline paracervical block for people requesting a surgical abortion at less than 14 weeks' gestation

Population: people requesting a surgical abortion at less than 14 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs normal saline paracervical block
no estimate extracted1 study · 150 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Pain with aspirationa,b
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs normal saline paracervical block
no estimate extracted1 study · 150 participantsLow
Downgraded: risk of bias, inconsistency
Pain during procedure ‐ not measured
Summary of findings table ‐ 20 mL 1% lidocaine paracervical block vs normal saline paracervical block
no estimate extractedNRNo studies

Summary of findings table ‐ 80 mg lidocaine paracervical block compared to normal saline paracervical block for people requesting a surgical abortion at seven weeks' gestation or less

Population: people requesting a surgical abortion at seven weeks' gestation or less
4 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ 80 mg lidocaine paracervical block vs normal saline paracervical block
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ 80 mg lidocaine paracervical block vs normal saline paracervical block
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ 80 mg lidocaine paracervical block vs normal saline paracervical block
no estimate extracted1 study · 54 participantsModerate
Downgraded: indirectness
Pain during procedure in women who also received topical cervical lidocaine spraya,b
Summary of findings table ‐ 80 mg lidocaine paracervical block vs normal saline paracervical block
no estimate extracted1 study · 54 participantsModerate
Downgraded: indirectness

Summary of findings table ‐ 14 mL 1% chloroprocaine paracervical block compared to normal saline paracervical block for women requesting a surgical abortion at seven to 12 weeks of gestation

Population: women requesting a surgical abortion at seven to 12 weeks of gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ 14 mL 1% chloroprocaine paracervical block vs normal saline paracervical block
no estimate extractedNRNo studies
Pain with aspirationa,b
Summary of findings table ‐ 14 mL 1% chloroprocaine paracervical block vs normal saline paracervical block
no estimate extracted1 study · 79 participantsHigh
Pain during procedure ‐ not measured
Summary of findings table ‐ 14 mL 1% chloroprocaine paracervical block vs normal saline paracervical block
no estimate extractedNRNo studies

Summary of findings table ‐ Ultracaine paracervical block compared to placebo (normal saline) paracervical block/no paracervical block for people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation

Population: people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Ultracaine paracervical block vs placebo (normal saline) paracervical block/no paracervical block
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Ultracaine paracervical block vs placebo (normal saline) paracervical block/no paracervical block
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Ultracaine paracervical block vs placebo (normal saline) paracervical block/no paracervical block
no estimate extracted1 study · 43 participantsLow
Downgraded: risk of bias, inconsistency, indirectness

Summary of findings table ‐ Topical cervical lidocaine spray compared to ultracaine paracervical block for people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation

Population: people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Topical cervical lidocaine spray vs ultracaine paracervical block
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Topical cervical lidocaine spray vs ultracaine paracervical block
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Topical cervical lidocaine spray vs ultracaine paracervical block
no estimate extracted1 study · 48 participantsModerate
Downgraded: indirectness

Summary of findings table ‐ Intravenous paracetamol compared to ultracaine paracervical block for people requesting a surgical abortion at 5+0 to 7+0 weeks? gestation

Population: people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Intravenous paracetamol vs ultracaine paracervical block
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Intravenous paracetamol vs ultracaine paracervical block
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Intravenous paracetamol vs ultracaine paracervical block
no estimate extracted1 study · 46 participantsModerate
Downgraded: indirectness

Summary of findings table ‐ Buffered lidocaine compared to plain lidocaine for people requesting a surgical abortion at 13+6 weeks? gestation or less (Chin 2020 included people experiencing an early pregnancy loss)

Population: people requesting a surgical abortion at 13+6 weeks' gestation or less (Chin 2020 included people experiencing an early pregnancy loss)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation (10 mL 2% lidocaine)a,b
Summary of findings table ‐ Buffered lidocaine vs plain lidocaine
no estimate extracted1 study · 167 participantsModerate
Downgraded: risk of bias
Pain with dilation (20 mL 1% lidocaine)d,e
Summary of findings table ‐ Buffered lidocaine vs plain lidocaine
no estimate extracted1 study · 98 participantsLow
Downgraded: imprecision
Pain with aspiration (lidocaine)a,b
Summary of findings table ‐ Buffered lidocaine vs plain lidocaine
no estimate extracted2 studies · 291 participantsModerate
Downgraded: risk of bias
Pain with aspiration (20 mL 1% lidocaine)d,e
Summary of findings table ‐ Buffered lidocaine vs plain lidocaine
no estimate extracted1 study · 98 participantsLow
Downgraded: imprecision

Summary of findings table ‐ 20 mL 1% plain lidocaine compared to 20 mL 0.25% bupivacaine for people requesting a surgical abortion in the first trimester

Population: people requesting a surgical abortion in the first trimester
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with aspirationa,b
Summary of findings table ‐ 20 mL 1% plain lidocaine vs 20 mL 0.25% bupivacaine
no estimate extracted1 study · 143 participantsLow
Downgraded: risk of bias, imprecision
Pain with dilation ‐ not measured
Summary of findings table ‐ 20 mL 1% plain lidocaine vs 20 mL 0.25% bupivacaine
no estimate extractedNRNo studies
Pain during procedure ‐ not measured
Summary of findings table ‐ 20 mL 1% plain lidocaine vs 20 mL 0.25% bupivacaine
no estimate extractedNRNo studies

Summary of findings table ‐ 20 mL 1% buffered lidocaine compared to 20 mL 0.25% bupivacaine for people requesting a surgical abortion in the first trimester

Population: people requesting a surgical abortion in the first trimester
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ 20 mL 1% buffered lidocaine vs 20 mL 0.25% bupivacaine
no estimate extractedNRNo studies
Pain with aspirationa,b
Summary of findings table ‐ 20 mL 1% buffered lidocaine vs 20 mL 0.25% bupivacaine
no estimate extracted1 study · 133 participantsModerate
Downgraded: risk of bias
Pain during procedure ‐ not measured
Summary of findings table ‐ 20 mL 1% buffered lidocaine vs 20 mL 0.25% bupivacaine
no estimate extractedNRNo studies

Summary of findings table ‐ 20 mL 1% lidocaine compared to 20 mL 0.5% lidocaine for people requesting a surgical abortion between seven and 14 weeks? gestation

Population: people requesting a surgical abortion between seven and 14 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ 20 mL 1% lidocaine vs 20 mL 0.5% lidocaine
no estimate extractedNRNo studies
Pain with aspirationa,b
Summary of findings table ‐ 20 mL 1% lidocaine vs 20 mL 0.5% lidocaine
no estimate extracted1 study · 209 participantsVery low
Downgraded: risk of bias, imprecision
Pain during procedure ‐ not measured
Summary of findings table ‐ 20 mL 1% lidocaine vs 20 mL 0.5% lidocaine
no estimate extractedNRNo studies

Summary of findings table ‐ Three‐ to five‐minute wait between paracervical block injection and cervical dilation compared to no wait between paracervical block injection and cervical dilation for people requesting a surgical abortion at less than 11 weeks? gestation

Population: people requesting a surgical abortion at less than 11 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ Three‐ to five‐minute wait between paracervical block injection and cervical dilation vs no wait between paracervical block injection and cervical dilation
no estimate extracted2 studies · 357 participantsModerate
Downgraded: risk of bias, inconsistency
Pain with aspirationa,b
Summary of findings table ‐ Three‐ to five‐minute wait between paracervical block injection and cervical dilation vs no wait between paracervical block injection and cervical dilation
no estimate extracted2 studies · 357 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Pain during procedure ‐ not measured
Summary of findings table ‐ Three‐ to five‐minute wait between paracervical block injection and cervical dilation vs no wait between paracervical block injection and cervical dilation
no estimate extractedNRNo studies

Summary of findings table ‐ 10 mL 2% cervical lignocaine gel compared to 10 mL cervical KY jelly for women requesting a surgical abortion between seven and 12 weeks' gestation

Population: women requesting a surgical abortion between seven and 12 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ 10 mL 2% cervical lignocaine gel vs 10 mL cervical KY jelly
no estimate extracted1 study · 131 participantsLow
Downgraded: risk of bias, imprecision, inconsistency
Pain with aspirationa,b
Summary of findings table ‐ 10 mL 2% cervical lignocaine gel vs 10 mL cervical KY jelly
no estimate extracted1 study · 131 participantsModerate
Downgraded: risk of bias, inconsistency
Pain during procedure ‐ not measured
Summary of findings table ‐ 10 mL 2% cervical lignocaine gel vs 10 mL cervical KY jelly
no estimate extractedNRNo studies

Summary of findings table ‐ Two pumps of 10% cervical lidocaine spray and paracervical block compared to two pumps of cervical normal saline spray and paracervical block for people requesting a surgical abortion at seven weeks' gestation or less

Population: people requesting a surgical abortion at seven weeks' gestation or less
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Two pumps of 10% cervical lidocaine spray and paracervical block vs two pumps of cervical normal saline spray and paracervical block
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Two pumps of 10% cervical lidocaine spray and paracervical block vs two pumps of cervical normal saline spray and paracervical block
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Two pumps of 10% cervical lidocaine spray and paracervical block vs two pumps of cervical normal saline spray and paracervical block
no estimate extracted1 study · 54 participantsModerate
Downgraded: indirectness

Summary of findings table ‐ Two puffs of cervical lidocaine spray compared to placebo cervical spray/no spray for people requesting a surgical abortion at 5+0 to 7+0 weeks? gestation

Population: people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Two puffs of cervical lidocaine spray vs placebo cervical spray/no spray
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Two puffs of cervical lidocaine spray vs placebo cervical spray/no spray
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Two puffs of cervical lidocaine spray vs placebo cervical spray/no spray
no estimate extracted1 study · 45 participantsLow
Downgraded: risk of bias, inconsistency, indirectness

Summary of findings table ‐ 3 cm deep paracervical block compared to 1.5 cm deep paracervical block for people requesting a surgical abortion at less than 12 weeks? gestation (Cetin 1997) and in the first trimester (Wiebe 1992)

Population: people requesting a surgical abortion at less than 12 weeks' gestation (Cetin 1997) and in the first trimester (Wiebe 1992)
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ 3 cm deep paracervical block vs 1.5 cm deep paracervical block
no estimate extracted2 studies · 229 participantsVery low
Downgraded: risk of bias, imprecision, inconsistency
Pain with aspirationa,b
Summary of findings table ‐ 3 cm deep paracervical block vs 1.5 cm deep paracervical block
no estimate extracted2 studies · 229 participantsLow
Downgraded: risk of bias, imprecision
Pain during procedure ‐ not measured
Summary of findings table ‐ 3 cm deep paracervical block vs 1.5 cm deep paracervical block
no estimate extractedNRNo studies

Summary of findings table ‐ 2 site (4‐8 o?clock) paracervical block compared to 4 site (2‐4‐8‐10 o?clock) paracervical block for people requesting a surgical abortion at less than 11 weeks? gestation (Renner 2016) and seven to 12 weeks? gestation (Glantz 2001)

Population: people requesting a surgical abortion at less than 11 weeks' gestation (Renner 2016) and seven to 12 weeks' gestation (Glantz 2001)
4 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilationa,b
Summary of findings table ‐ 2 site (4‐8 o?clock) paracervical block vs 4 site (2‐4‐8‐10 o?clock) paracervical block
no estimate extracted1 study · 163 participantsHigh
Pain with aspiration – normal salined,e
Summary of findings table ‐ 2 site (4‐8 o?clock) paracervical block vs 4 site (2‐4‐8‐10 o?clock) paracervical block
no estimate extracted1 study · 41 participantsModerate
Downgraded: imprecision
Pain with aspiration – local anaesthetica,b,d,e
Summary of findings table ‐ 2 site (4‐8 o?clock) paracervical block vs 4 site (2‐4‐8‐10 o?clock) paracervical block
no estimate extracted2 studies · 201 participantsModerate
Downgraded: imprecision
Pain during procedure ‐ not measured
Summary of findings table ‐ 2 site (4‐8 o?clock) paracervical block vs 4 site (2‐4‐8‐10 o?clock) paracervical block
no estimate extractedNRNo studies

Summary of findings table ‐ Intravenous paracetamol 1000 mg compared to 2 pumps of cervical lidocaine spray for people requesting a surgical abortion at 5+0 to 7+0 weeks? gestation

Population: people requesting a surgical abortion at 5+0 to 7+0 weeks' gestation
3 questions
OutcomeEffectEvidenceStatus / GRADE
Pain with dilation ‐ not measured
Summary of findings table ‐ Intravenous paracetamol 1000 mg vs 2 pumps of cervical lidocaine spray
no estimate extractedNRNo studies
Pain with aspiration ‐ not measured
Summary of findings table ‐ Intravenous paracetamol 1000 mg vs 2 pumps of cervical lidocaine spray
no estimate extractedNRNo studies
Pain during procedurea,b
Summary of findings table ‐ Intravenous paracetamol 1000 mg vs 2 pumps of cervical lidocaine spray
no estimate extracted1 study · 48 participantsLow
Downgraded: imprecision, indirectness